Home › Funds › CULLEN/FROST BANKERS, INC. › JNJ

CULLEN/FROST BANKERS, INC. position in JNJ

JOHNSON & JOHNSON · Health Care

CULLEN/FROST BANKERS, INC. reported holding 289,954 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$76.8M, representing 0.75% of its reported portfolio and ranking #29 among its reported holdings. CULLEN/FROST BANKERS, INC. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)289.95K sh
Reported value held$76.76M
Portfolio Weight0.75%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CULLEN/FROST BANKERS, INC.'s JNJ position evolved

CULLEN/FROST BANKERS, INC. first disclosed a stake in JNJ in Q3 2023 at 361,151 shares (US$56.2M). The position peaked in Q2 2026 at 308,337 shares, worth US$78.3M. Across 13 filings, CULLEN/FROST BANKERS, INC. increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 289,954 shares valued at US$76.8M — a reduction of -18,383 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 361.15K $56.25M New
Q4 2023 344.76K $54.04M Reduce
Q1 2024 342.40K $54.16M Reduce
Q2 2024 337.32K $49.30M Reduce
Q3 2024 341.91K $55.41M Add
Q4 2024 342.42K $49.52M Hold
Q1 2025 344.65K $57.16M Add
Q2 2025 334.98K $51.17M Reduce
Q3 2025 325.49K $60.35M Reduce
Q4 2025 314.25K $65.03M Reduce
Q1 2026 309.15K $75.57M Reduce
Q2 2026 308.34K $78.31M Hold
Q3 2026 289.95K $76.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has CULLEN/FROST BANKERS, INC. held JNJ?

CULLEN/FROST BANKERS, INC. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CULLEN/FROST BANKERS, INC.'s current position in JNJ?

As of Q3 2026, CULLEN/FROST BANKERS, INC. holds 289.95K shares of JNJ (JOHNSON & JOHNSON), valued at $76.76M, representing 0.75% of its reported portfolio and ranking #29.

Has CULLEN/FROST BANKERS, INC. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), CULLEN/FROST BANKERS, INC. reduced its position in JNJ. The position peaked in Q2 2026 at 308.34K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.